The sales were disclosed in an SEC filing and reported pursuant to a Rule 10b5-1 trading plan, the report said.
Mr. Miles’ stock sale comes just over a month after the company reported $177 million second quarter revenue, a 39 percent increase year-over-year. The company also saw a banner year in 2022 with a 44 percent revenue jump.
This year, Alphatec is expecting its 2023 revenue to grow 32 percent year-over-year.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
